| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | NEXT Insurance | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $3.28B | Series G | 11/1/2023 | $265M | $2.53B | $2.57 | Allstate, Allianz X | ||||
 | Omaze | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $152.17M | Series C-2 | 9/16/2021 | $11.05M | $911.25M | $10.07 | Moore Strategic Ventures, FirstMark Capital, Wndrco, Telstra Ventures, Causeway Media Partners, Mockingbird Ventures, BDMI, Pegasus Ventures | ||||
 | Paradigm | Fintech Capital Markets | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Paragon 28 | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Pasqal | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | PathAI | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $255.49M | Series C | 5/19/2021 | $165M | $1.11B | $29.50 | D1 Capital Partners, Kaiser Permanente, General Atlantic, Tiger Global Management, 8VC, Adage, Biospring Partners, General Catalyst, KdT Ventures, Polaris Partners, Refactor Capital, Bristol-Myers Squibb Company, Labcorp, Merck Global Health Innovation Fund | ||||
 | PAX Labs | Consumer & Lifestyle Cannabis & Tobacco | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $151.67K | -- | 1 | Not available | -- | -- | $117.59M | Series B | 4/22/2019 | $10.71M | $143.89M | $0.19 | Tiger Global Management, Tao Capital Partners, Prescott General Partners | ||||
 | PayJoy | Fintech Lending | Low | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $181.77M | Series C | 9/5/2023 | $140M | $656.99M | $10.24 | Warburg Pincus, Invus, Citi Ventures, Union Square Ventures, Greylock | ||||
 | People.ai | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $211.81M | Series D | 8/11/2021 | $77.09M | $1.1B | $34.88 | Akkadian Ventures, Mubadala Capital, ICONIQ Capital, Lightspeed Venture Partners | ||||
 | Plenful | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $66M | Series B | 4/30/2025 | $40M | $486.84M | $23.90 | Mitchell Rales, Arena Holdings, Notable Capital, Bessemer Venture Partners, TQ Ventures, Susa Ventures, Kivu Ventures | ||||
 | Poppi | Consumer & Lifestyle E-commerce | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Premier Lacrosse League | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $231.56M | Series E | 6/30/2026 | $100M | $548.43M | $10.90 | Ares Management, Joe Tsai Sports, ESPN, Glen Powell, Rob Mac, Warren Zeiders, Tony Cavalero, Creator Sports Capital, Next 3, FirstTracks Sports Ventures, Jed Hart, West End Investment Management, James Young, Bolt Ventures, Chris Shumway | ||||
 | Preply | Education Other Education | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $140.97K | -- | 1 | Not available | -- | -- | $264.72M | Series D | 1/21/2026 | $100M | $1.2B | $7.06 | WestCap, EBRD, Horizon Capital | ||||
 | Project44 | Industrial Logistics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.46B | Series F | 11/3/2022 | $320.12M | $2.7B | $5.56 | Generation Investment Management, A.P. Moller Holding, Thoma Bravo, TPG, Goldman Sachs, Emergence Capital, Insight Partners, Chicago Ventures, Sapphire, Sozo Ventures, Sixth Street, 8VC, Omidyar Technology Ventures | ||||
 | Qonto | Fintech Digital Banking | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | R3 | Fintech Other Fintech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | RapidAI | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $93.84M | Series C | 7/27/2023 | $75M | $667.51M | $55.44 | Vista Equity Partners | ||||
 | Ridecell | Transportation Ridesharing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $288.65M | Series C-3 | 4/13/2023 | $26.29M | $706.25M | $9.95 | Undisclosed Investors | ||||
 | Riverside | Consumer & Lifestyle Consumer Applications | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $76.93M | Series A-3 | 12/9/2024 | $30M | $454.07M | $23.67 | Zeev Ventures, Seven Seven Six, Sam Lessin | ||||
 | Scribd | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $74.54M | Series E | 11/25/2019 | $25M | $429.65M | $13.80 | Spectrum Equity | ||||
 | Seyond | Transportation Autonomous Vehicles | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Sonoma Biotherapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $365.1M | Series B-1 | 3/28/2023 | $147.78M | $732.39M | $2.96 | Ally Bridge Group, ArrowMark, Avidity Partners, Casdin Capital, Deep Track Capital, Fidelity Management, Frazier Healthcare Partners, GV, Janus Henderson Investors, Mirae Asset, NS Investment, Osage University Partners, Piper Heartland Healthcare Capital, Vertex Ventures HC, 8VC, ARCH Venture Partners, Alexandria Venture Investments, JDRF T1D Fund, LifeForce Capital, Lilly Asia Ventures Biosciences, Octagon Capital, Regeneron | ||||
 | Spotnana | Transportation Other Transportation | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $230M | Series C | 1/15/2026 | $85M | $1.11B | $4.78 | Undisclosed Investors | ||||
 | Spyglass Pharma | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $200.88M | Series D | 6/2/2025 | $77.33M | $363.51M | $13.33 | Sands Capital, Gilde Healthcare, New Enterprise Associates, RA Capital Management, Censana Capital, Samsara BioCapital, Vertex Ventures HC | ||||